Giant prolactinoma in children and adolescents: a single-center experience and systematic review

[1]  A. Alikaşifoğlu,et al.  Management of prolactinomas in children and adolescents; which factors define the response to treatment? , 2021, Pituitary.

[2]  S. Gaztambide,et al.  Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas. , 2021, European journal of endocrinology.

[3]  S. Aylwin,et al.  Prolactinoma in childhood and adolescence—Tumour size at presentation predicts management strategy: Single centre series and a systematic review and meta‐analysis , 2020, Clinical endocrinology.

[4]  M. Zacharin,et al.  Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism , 2020, Pituitary.

[5]  N. Shah,et al.  Predictors of chronic LH-testosterone axis suppression in male macroprolactinomas with normoprolactinemia on cabergoline. , 2020, The Journal of clinical endocrinology and metabolism.

[6]  D. Kong,et al.  Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center , 2020, Frontiers in Endocrinology.

[7]  H. Teede,et al.  Adolescent polycystic ovary syndrome according to the international evidence-based guideline , 2020, BMC Medicine.

[8]  G. Valk,et al.  Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review , 2019, Front. Endocrinol..

[9]  D. Grattan,et al.  Impaired hypothalamic leptin sensitivity in pseudopregnant rats treated with chronic prolactin to mimic pregnancy , 2019, Journal of neuroendocrinology.

[10]  P. Chanson,et al.  The epidemiology, diagnosis and treatment of Prolactinomas:The old and the new. , 2019, Best practice & research. Clinical endocrinology & metabolism.

[11]  J. V. Van Gompel,et al.  MANAGEMENT AND OUTCOMES OF GIANT PROLACTINOMA: A SERIES OF 71 PATIENTS. , 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  I. Shimon.  Giant Prolactinomas , 2018, Neuroendocrinology.

[13]  U. Pagotto,et al.  Normative Basal Values of Hormones and Proteins of Gonadal and Adrenal Functions from Birth to Adulthood , 2018, Sexual Development.

[14]  H. Yoo,et al.  Broad clinical spectrum and diverse outcomes of prolactinoma with pediatric onset: medication-resistant and recurrent cases. , 2018, Endocrine journal.

[15]  A. Claviez,et al.  Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis , 2017, European Journal of Pediatrics.

[16]  S. Khare,et al.  Gender differences in macroprolactinomas: a single centre experience , 2015, Endocrine connections.

[17]  V. Mendoza,et al.  Giant prolactinomas: are they really different from ordinary macroprolactinomas? , 2016, Endocrine.

[18]  A. Khadilkar,et al.  Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5–18-year-old Indian children , 2015, Indian journal of endocrinology and metabolism.

[19]  O. Dekkers,et al.  Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG). , 2015, The Journal of clinical endocrinology and metabolism.

[20]  P. Chanson,et al.  New insights in prolactin: pathological implications , 2015, Nature Reviews Endocrinology.

[21]  P. Chanson,et al.  Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. , 2015, The Journal of clinical endocrinology and metabolism.

[22]  E. Hugo,et al.  Prolactin (PRL) in adipose tissue: regulation and functions. , 2015, Advances in experimental medicine and biology.

[23]  E. Mannucci,et al.  Factors affecting spermatogenesis upon gonadotropin‐replacement therapy: a meta‐analytic study , 2014, Andrology.

[24]  D. Maiter,et al.  Therapy of endocrine disease: the challenges in managing giant prolactinomas. , 2014, European journal of endocrinology.

[25]  M. Andersen,et al.  Giant prolactinomas in women. , 2014, European journal of endocrinology.

[26]  M. Gadelha,et al.  Giant prolactinomas: the therapeutic approach , 2013, Clinical endocrinology.

[27]  A. Tabarin,et al.  High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. , 2011, European journal of endocrinology.

[28]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[29]  R. Paschke,et al.  Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. , 2010, The Journal of clinical endocrinology and metabolism.

[30]  J. Lachuer,et al.  Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. , 2010, The Journal of clinical endocrinology and metabolism.

[31]  R. Paschke,et al.  Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. , 2010, The Journal of clinical endocrinology and metabolism.

[32]  S. Joshi,et al.  Clinical profile and long term follow up of children and adolescents with prolactinomas , 2008, Pituitary.

[33]  J. Wass,et al.  Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features. , 2007, The Journal of clinical endocrinology and metabolism.

[34]  J. Donckier,et al.  Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. , 1997, The Journal of clinical endocrinology and metabolism.

[35]  A. Grossman,et al.  PROLACTINOMAS PRESENTING AS PRIMARY AMENORRHOEA AND DELAYED OR ARRESTED PUBERTY: RESPONSE TO MEDICAL THERAPY , 1989, Clinical endocrinology.

[36]  J. Carter,et al.  Prolactin-screening tumors and hypogonadism in 22 men. , 1978, The New England journal of medicine.

[37]  G. di Chiro,et al.  The volume of the sella turcica. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.